Feline Pipeline

Non-regenerative Anemia in Cats

KIND-510a


KIND-510a

POSITIVE RESULTS FROM PILOT EFFECTIVENESS STUDY OF FELINE RECOMBINANT ERYTHROPOIETIN

“Anemia has been associated with progression in feline chronic kidney disease, and potentially contributes to renal hypoxia, as well as decreased energy and appetite. Therefore recognition and treatment of anemia is an essential part of management of CKD.”

- Jessica Quimby, DVM, Ph.D., DACVIM

Pivotal study began in the third quarter of 2019

Chronic condition estimated to afflict millions of older cats, with no approved treatments.

About 50 percent of older cats develop chronic kidney disease (CKD), which can lead to anemia.

CKD is a leading cause of feline mortality and veterinary visits.

Human erythropoietins are multi-billion dollar products in human market, but immunogenic in many cats.

Learn More About:

KindredBio Investor Relations Non-regenerative Anemia in Cats

US-CORP-1900168 FEB-20

Feline Pipeline

Non-regenerative Anemia in Cats

KIND-510a

News

Events